Bank of Montreal Can Acquires 159,036 Shares of MEDNAX Inc (MD)

Bank of Montreal Can raised its stake in shares of MEDNAX Inc (NYSE:MD) by 212.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 233,920 shares of the company’s stock after purchasing an additional 159,036 shares during the period. Bank of Montreal Can owned 0.25% of MEDNAX worth $12,500,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MD. Fuller & Thaler Asset Management Inc. purchased a new stake in MEDNAX in the 3rd quarter worth about $103,000. Denali Advisors LLC purchased a new stake in MEDNAX in the 3rd quarter worth about $185,000. Meiji Yasuda Asset Management Co Ltd. raised its position in MEDNAX by 45.3% in the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 5,230 shares of the company’s stock worth $226,000 after purchasing an additional 1,630 shares during the period. QS Investors LLC increased its position in shares of MEDNAX by 0.3% during the second quarter. QS Investors LLC now owns 3,812 shares of the company’s stock worth $230,000 after acquiring an additional 12 shares during the period. Finally, YHB Investment Advisors Inc. purchased a new position in shares of MEDNAX during the fourth quarter worth approximately $235,000. 95.22% of the stock is owned by institutional investors and hedge funds.

MEDNAX Inc (NYSE:MD) opened at $54.39 on Tuesday. MEDNAX Inc has a fifty-two week low of $40.56 and a fifty-two week high of $72.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.43 and a quick ratio of 1.37. The firm has a market cap of $5,130.00, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 1.47 and a beta of 0.31.

MEDNAX (NYSE:MD) last released its earnings results on Thursday, February 8th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.04. The business had revenue of $910.82 million during the quarter, compared to analysts’ expectations of $884.55 million. MEDNAX had a net margin of 9.26% and a return on equity of 10.10%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.00 earnings per share. equities research analysts expect that MEDNAX Inc will post 3.67 EPS for the current fiscal year.

A number of equities analysts have recently commented on the stock. Stephens set a $62.00 target price on shares of MEDNAX and gave the stock a “buy” rating in a research report on Thursday, February 8th. Citigroup cut their price objective on shares of MEDNAX from $52.00 to $47.00 and set a “neutral” rating on the stock in a report on Friday, November 3rd. Zacks Investment Research raised shares of MEDNAX from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a report on Tuesday, January 23rd. JPMorgan Chase & Co. raised their target price on shares of MEDNAX from $46.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday. Finally, Jefferies Group set a $50.00 target price on shares of MEDNAX and gave the company a “hold” rating in a research note on Tuesday, February 6th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $54.92.

In related news, insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction dated Tuesday, December 12th. The shares were sold at an average price of $51.58, for a total transaction of $154,740.00. Following the transaction, the insider now directly owns 35,569 shares in the company, valued at $1,834,649.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.40% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Bank of Montreal Can Acquires 159,036 Shares of MEDNAX Inc (MD)” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/13/bank-of-montreal-can-increases-position-in-mednax-inc-md.html.

MEDNAX Profile

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Institutional Ownership by Quarter for MEDNAX (NYSE:MD)

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply